Insulinoma cases datanote.xlsx

We procured the the detailed clinical information of the 24 in-patients with insulinoma. Demographic characteristics and clinical baseline data were collected. Severity of hypoglycemia was measured as follows: self-perceptible symptoms of hypoglycemia, average values of fasting blood glucose, frequency of hypoglycemic attacks, weight, body mass index (BMI) and weight change. Data about RCS supplementation was obtained, including the dosage of RCS ingested per time, dosing interval, ingestion time, duration of nutrition therapy and its therapeutic effect on blood glucose and weight change. Adverse events associated with the RCS intervention were also recorded during the nutritional management.